Skip to Main Content

Paper Details

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
Oncogene
62
2018
BET, BET bromodomain, BET bromodomains, CDK2, CDKs, Group, MB, MB cells, MYC, MYC genes, MYC target gene, MYC-driven medulloblastoma, MYCN, Medulloblastoma, RNA, cancer, children, cyclin-dependent kinases, doxycycline, human, lysine, malignant brain tumor, tumor, tumor cells
Author NameAffiliation
Jun QiHarvard Medical School Department of Medical Oncology, Dana-Farber Cancer Institute
James E BradnerHarvard Medical School Department of Medical Oncology, Dana-Farber Cancer Institute
William A WeissUniversity of California san francisco
William A WeissUniversity of California san francisco
  • 1 - 4

Datasets

Release 1.2